Health Services Management Department, Guizhou Medical University, Gui'an, China.
Center of Medicine Economics and Management Research, Guizhou Medical University, Gui'an, China.
Health Qual Life Outcomes. 2023 Jun 20;21(1):59. doi: 10.1186/s12955-023-02131-z.
Cost-utility analysis (CUA) is the preferred form of economic evaluation in many countries. As one of the key data inputs in cost-utility models, health state utility (HSU) has a crucial impact on CUA results. In the past decades, health technology assessment has been expanding rapidly in Asia, yet research examining the methodology and process used to generate cost-effectiveness evidence is scarce. The aim of this study was to examine the reporting of the characteristics of HSU data used in CUAs in Asia and how the characteristics have changed over time.
A systematic literature search was performed to identify published CUA studies targeting Asian populations. Information was extracted for both the general characteristics of selected studies and the characteristics of reported HSU data. For each HSU value identified, we extracted data for four key characteristics, including 1) estimation method; 2) source of health-related quality of life (HRQoL) data; 3) source of preference data; and 4) sample size. The percentage of nonreporting was calculated and compared over two time periods (1990-2010 vs 2011-2020).
A total of 789 studies were included and 4,052 HSUs were identified. Of these HSUs, 3,351 (82.7%) were from published literature and 656 (16.2%) were from unpublished empirical data. Overall, the characteristics of HSU data were not reported in more than 80% of the studies. Of HSUs whose characteristics were reported, most of them were estimated using the EQ-5D (55.7%), Asian HRQoL data (91.9%), and Asian health preferences (87.7%); 45.7% of the HSUs was estimated with a sample of 100 or more individuals. All four characteristics showed improvements after 2010.
Over the past two decades, there has been a significant increase in CUA studies targeting Asian populations. However, HSU's characteristics were not reported in most of the CUA studies, making it difficult to evaluate the quality and appropriateness of the HSUs used in those cost-effectiveness studies.
成本效用分析(CUA)是许多国家首选的经济评估形式。作为成本效用模型中的关键数据输入之一,健康状态效用(HSU)对 CUA 结果有至关重要的影响。在过去几十年中,亚洲的卫生技术评估迅速发展,但研究考察用于生成成本效益证据的方法和过程的研究却很少。本研究旨在考察亚洲人群中 CUA 使用的 HSU 数据的报告特点,以及这些特点随时间的变化情况。
进行了系统的文献检索,以确定针对亚洲人群的已发表的 CUA 研究。提取了所选研究的一般特征以及报告的 HSU 数据的特征信息。对于确定的每个 HSU 值,我们提取了四个关键特征的数据,包括 1)估计方法;2)健康相关生活质量(HRQoL)数据来源;3)偏好数据来源;4)样本量。计算了非报告的百分比,并在两个时间段(1990-2010 年与 2011-2020 年)之间进行了比较。
共纳入 789 项研究,确定了 4052 个 HSU。其中,3351 个(82.7%)HSU 来自已发表文献,656 个(16.2%)HSU 来自未发表的实证数据。总体而言,超过 80%的研究未报告 HSU 数据的特征。在报告了特征的 HSU 中,大多数使用 EQ-5D(55.7%)、亚洲 HRQoL 数据(91.9%)和亚洲健康偏好(87.7%)进行估计;45.7%的 HSU 是用 100 个或更多个体的样本进行估计的。所有四个特征在 2010 年以后都有所改善。
在过去的二十年中,针对亚洲人群的 CUA 研究有了显著增加。但是,大多数 CUA 研究都没有报告 HSU 的特征,这使得难以评估那些成本效益研究中使用的 HSU 的质量和适当性。